Intuitive Surgical was part of Galvanize Therapeutics’ $100m series B round while Intel Capital participated in a $90m series C for Fortanix.
Next47 has participated in a $205m series D round for Verkada while UPMC Enterprises has co-led SparingVision’s $75m series B.
Pfizer Ventures has led a $102m series A for Capstan Therapeutics while Globis Capital Partners took part in an $85.4m round for Andpad.
Access Industries, Pfizer and SR One were among the investors in a $125m round for Nimbus Therapeutics while Aerwins agreed a reverse takeover.
Hanwha Group took part in a $250m round for Carrot General Insurance while JP Morgan Chase helped lift LetsGetChecked’s series D to $170m.
Reliance Egypt participated in Trukker’s $100m series C round while Merck, Eli Lilly and Heritage Medical all backed Photys’ $75m series A.
SHV and DELA took part in an $80m round for Lightyear while Tata Sons provided $40m in funding for Tata 1mg.
Eli Lilly took part in a $50m series A1 round for Neukio Biotherapeutics while Itochu led Docquity’s $44m series C.
SK has provided $50m in funding for Ascend Elements while ServiceNow took part in a $35.6m series C round for Fairmarkit.
Peijia Medical participated in JenaValve’s $100m series C round while L Catterton led Planted Foods’ series B extension, lifting it to $93m.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
